Optimal anticoagulation in patients with atrial fibrillation and bioprosthetic heart valves | Zendy

Roberta Bottino | Zendy; Andreina Carbone | Zendy; Biagio Liccardo | Zendy; Egidio Imbalzano | Zendy; Antonello D’Andrea | Zendy; Vincenzo Russo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Optimal anticoagulation in patients with atrial fibrillation and bioprosthetic heart valves

Author(s) -

Roberta Bottino,

Andreina Carbone,

Biagio Liccardo,

Egidio Imbalzano,

Antonello D’Andrea,

Vincenzo Russo

Publication year - 2022

Publication title -

kardiologia polska

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.527

H-Index - 34

eISSN - 1897-4279

pISSN - 0022-9032

DOI - 10.33963/kp.a2022.0051

Subject(s) - medicine , antithrombotic , atrial fibrillation , cardiology , valve replacement , heart valve , surgery , stenosis

The antithrombotic management of patients after surgical or transcatheter bioprosthetic heart valves (BHVs) replacement is still challenging. Our review aims to describe the current evidence on the best antithrombotic strategy among patients undergoing BHVs replacement (surgical or transcatheter) and/or valve repair, with particular attention to those with atrial fibrillation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research